Profound Cardiac Sympathetic Denervation Occurs in Parkinson Disease

Overview

Journal Brain Pathol

Date 2005 Mar 23

PMID 15779234

Citations 67

Authors

Takeshi Amino

Satoshi Orimo

Yoshinori Itoh

Atsushi Takahashi

Toshiki Uchihara

Hidehiro Mizusawa

Affiliations

Soon will be listed here.

Abstract

In the last few years, cardiac sympathetic dysfunction in Parkinson disease (PD) has been postulated on the basis of decreased cardiac uptake of sympathoneural imaging tracers. However, the pathological substrate for the dysfunction remains to be established. We examined the left ventricular anterior wall from postmortem specimens with immunohistochemical staining for tyrosine hydroxylase (TH), neurofilament (NF) and S-100 protein in PD patients and control subjects, and quantified the immunoreactive areas. As TH-immunoreactive axons nearly disappeared and NF-immunoreactive axons drastically decreased in number, the morphological degeneration of the cardiac sympathetic nerves in PD was confirmed. Quantitative analysis showed that sympathetic nerves were preferentially involved. Triple immunofluorolabeling for NF, TH, and myelin basic protein showed clearly the profound involvement of sympathetic axons in PD. The extent of involvement of the cardiac sympathetic nerves seems likely to be equivalent to that in the central nervous system, including the nigrostriatal dopaminergic system. PD affects the cardiac sympathetic nervous system profoundly as well as nigrostriatal dopaminergic system.

Citing Articles

Pathophysiological Significance of α-Synuclein in Sympathetic Nerves: In Vivo Observations.

Isonaka R, Sullivan P, Goldstein D Neurology. 2025; 104(3):e210215.

PMID: 39805051 PMC: 11735147. DOI: 10.1212/WNL.0000000000210215.

α-synuclein seed amplification assay sensitivity may be associated with cardiac MIBG abnormality among patients with Lewy body disease.

Kurihara M, Satoh K, Shimasaki R, Hatano K, Ohse K, Taira K NPJ Parkinsons Dis. 2024; 10(1):190.

PMID: 39433540 PMC: 11494045. DOI: 10.1038/s41531-024-00806-y.

Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).

Khalil I, Sayad R, Kedwany A, Sayed H, Caprara A, Rissardo J Med Int (Lond). 2024; 4(6):70.

PMID: 39355336 PMC: 11443310. DOI: 10.3892/mi.2024.194.

Chronotropic Incompetence in Parkinson's Disease: A Possible Marker of Severe Disease Phenotype?.

Andreasson M, Nickander J, Stahlberg M, Fedorowski A, Svenningsson P J Parkinsons Dis. 2024; 14(3):557-563.

PMID: 38517804 PMC: 11091571. DOI: 10.3233/JPD-230256.

Mechanisms of Swallowing, Speech and Voice Disorders in Parkinson's Disease: Literature Review with Our First Evidence for the Periperal Nervous System Involvement.

Mu L, Chen J, Li J, Nyirenda T, Hegland K, Beach T Dysphagia. 2024; 39(6):1001-1012.

PMID: 38498201 DOI: 10.1007/s00455-024-10693-3.

References

Li S, Dendi R, Holmes C, Goldstein D . Progressive loss of cardiac sympathetic innervation in Parkinson's disease. Ann Neurol. 2002; 52(2):220-3. DOI: 10.1002/ana.10236. View

Chiueh C, Kirk K, Kopin I . 6-Fluorocatecholamines as false adrenergic neurotransmitters. J Pharmacol Exp Ther. 1983; 225(3):529-33. View

Goto K, Longhurst P, Cassis L, Head R, Taylor D, Rice P . Surgical sympathectomy of the heart in rodents and its effect on sensitivity to agonists. J Pharmacol Exp Ther. 1985; 234(1):280-7. View

Petch M, NAYLER W . Concentration of catecholamines in human cardiac muscle. Br Heart J. 1979; 41(3):340-4. PMC: 482037. DOI: 10.1136/hrt.41.3.340. View

Takahashi A . Autonomic nervous system disorders in Parkinson's disease. Eur Neurol. 1991; 31 Suppl 1:41-7. DOI: 10.1159/000116720. View

Van Stee E . Autonomic innervation of the heart. Environ Health Perspect. 1978; 26:151-8. PMC: 1637264. DOI: 10.1289/ehp.7826151. View

Wieland D, Brown L, Tobes M, Rogers W, Marsh D, Mangner T . Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med. 1981; 22(4):358-64. View

Schuurman H, Plomp S, Wijngaard P, Slootweg P, de Jonge N . Innervation of the endomyocardium in the first period after heart transplantation. Transplantation. 1993; 56(1):85-8. DOI: 10.1097/00007890-199307000-00015. View

Haapaniemi T, Pursiainen V, Korpelainen J, Huikuri H, Sotaniemi K, Myllyla V . Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001; 70(3):305-10. PMC: 1737270. DOI: 10.1136/jnnp.70.3.305. View

10.

Reinhardt M, Jungling F, Krause T, Braune S . Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake. Eur J Nucl Med. 2000; 27(5):595-600. DOI: 10.1007/s002590050548. View

11.

Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K . Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002; 73(6):776-7. PMC: 1757347. DOI: 10.1136/jnnp.73.6.776. View

12.

Chow L, Chow W, Lee J, Chow S, Anderson R, Gosling J . Postmortem changes in the immunohistochemical demonstration of nerves in human ventricular myocardium. J Anat. 1998; 192 ( Pt 1):73-80. PMC: 1467740. DOI: 10.1046/j.1469-7580.1998.19210073.x. View

13.

Lloyd K, Davidson L, Hornykiewicz O . The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther. 1975; 195(3):453-64. View

14.

Uchihara T, Nakamura A, Nakayama H, Arima K, Ishizuka N, Mori H . Triple immunofluorolabeling with two rabbit polyclonal antibodies and a mouse monoclonal antibody allowing three-dimensional analysis of cotton wool plaques in Alzheimer disease. J Histochem Cytochem. 2003; 51(9):1201-6. DOI: 10.1177/002215540305100910. View

15.

Mogi M, Harada M, Kiuchi K, Kojima K, Kondo T, Narabayashi H . Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain. J Neural Transm. 1988; 72(1):77-82. DOI: 10.1007/BF01244634. View

16.

Neubauer B, Christensen N . Norepinephrine, epinephrine, and dopamine contents of the cardiovascular system in long-term diabetics. Diabetes. 1976; 25(1):6-10. DOI: 10.2337/diab.25.1.6. View

17.

Kawano H, Ryozo Okada , Yano K . Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels. 2003; 18(1):32-9. DOI: 10.1007/s003800300005. View

18.

McGeer P, McGeer E . Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem. 1976; 26(1):65-76. View

19.

Yoshita M . Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci. 1998; 155(1):60-7. DOI: 10.1016/s0022-510x(97)00278-5. View

20.

Taki J, Nakajima K, Hwang E, Matsunari I, Komai K, Yoshita M . Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp. Eur J Nucl Med. 2000; 27(5):566-73. DOI: 10.1007/s002590050544. View